Surgical management of noncolorectal cancer liver metastases.

作者: Andrew J. Page , Matthew J. Weiss , Timothy M. Pawlik

DOI: 10.1002/CNCR.28743

关键词:

摘要: The number of hepatectomies performed for metastatic cancer has dramatically increased over the past 2 decades. Hepatectomy stage IV colorectal is now considered standard care resectable patients with isolated hepatic disease and acceptable performance status. However, indications resection noncolorectal origin liver metastases are not as clearly defined. This review focuses on emerging data to liver, a focus surgical resection. Specifically, we current management nonneuroendocrine neuroendocrine tumors liver. Cancer 2014;120:3111–3121. © 2014 American Society.

参考文章(95)
Ilstrup Dm, van Heerden Ja, Thompson Gb, Grant Cs, Carney Ja, Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery. ,vol. 104, pp. 1011- ,(1988)
Ronald S Chamberlain, David Canes, Karen T Brown, Leonard Saltz, William Jarnagin, Yuman Fong, Leslie H Blumgart, Hepatic neuroendocrine metastases: does intervention alter outcomes?11No competing interests declared. Journal of the American College of Surgeons. ,vol. 190, pp. 432- 445 ,(2000) , 10.1016/S1072-7515(00)00222-2
Ryan S. Turley, Peter D. Peng, Srinevas K. Reddy, Andrew S. Barbas, David A. Geller, J. Wallis Marsh, Allan Tsung, Timothy M. Pawlik, Bryan M. Clary, Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Cancer. ,vol. 118, pp. 3571- 3578 ,(2012) , 10.1002/CNCR.26650
Sanjiv S. Agarwala, Alexander M. M. Eggermont, Steven O'Day, Jonathan S. Zager, Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options Cancer. ,vol. 120, pp. 781- 789 ,(2014) , 10.1002/CNCR.28480
Sanjay Gupta, Marcella M. Johnson, Ravi Murthy, Kamran Ahrar, Michael J. Wallace, David C. Madoff, Stephen E. McRae, Marshall E. Hicks, Sujaya Rao, Jean-Nicolas Vauthey, Jaffer A. Ajani, James C. Yao, Hepatic Arterial Embolization and Chemoembolization for the Treatment of Patients with Metastatic Neuroendocrine Tumors Variables Affecting Response Rates and Survival Cancer. ,vol. 104, pp. 1590- 1602 ,(2005) , 10.1002/CNCR.21389
Rebecca Siegel, Elizabeth Ward, Otis Brawley, Ahmedin Jemal, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 212- 236 ,(2011) , 10.3322/CAAC.20121
Seung Wook Ryu, Robyn Saw, Richard A. Scolyer, Michael Crawford, John F. Thompson, Charbel Sandroussi, Liver resection for metastatic melanoma: Equivalent survival for cutaneous and ocular primaries Journal of Surgical Oncology. ,vol. 108, pp. 129- 135 ,(2013) , 10.1002/JSO.23361
Marcus C.B. Tan, William R. Jarnagin, Surgical management of non‐colorectal hepatic metastasis Journal of Surgical Oncology. ,vol. 109, pp. 8- 13 ,(2014) , 10.1002/JSO.23462
Jacques Belghiti, Kazuhiro Hiramatsu, Stéphane Benoist, Pierre Philippe Massault, Alain Sauvanet, Olivier Farges, Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. Journal of The American College of Surgeons. ,vol. 191, pp. 38- 46 ,(2000) , 10.1016/S1072-7515(00)00261-1
Paul B. Chapman, Lawrence H. Einhorn, Michael L. Meyers, Scott Saxman, Alicia N. Destro, Katherine S. Panageas, Colin B. Begg, Sanjiv S. Agarwala, Lynn M. Schuchter, Marc S. Ernstoff, Alan N. Houghton, John M. Kirkwood, Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma Journal of Clinical Oncology. ,vol. 17, pp. 2745- 2751 ,(1999) , 10.1200/JCO.1999.17.9.2745